A
Price
$125.47
Change
+$0.51 (+0.41%)
Updated
Aug 29, 01:50 PM (EDT)
Capitalization
35.5B
94 days until earnings call
TMO
Price
$491.87
Change
+$2.12 (+0.43%)
Updated
Aug 29, 12:07 PM (EDT)
Capitalization
184.93B
54 days until earnings call
Interact to see
Advertisement

A vs TMO

Header iconA vs TMO Comparison
Open Charts A vs TMOBanner chart's image
Agilent Technologies
Price$125.47
Change+$0.51 (+0.41%)
Volume$200
Capitalization35.5B
Thermo Fisher Scientific
Price$491.87
Change+$2.12 (+0.43%)
Volume$900
Capitalization184.93B
A vs TMO Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. TMO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and TMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (A: $124.96 vs. TMO: $489.74)
Brand notoriety: A and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 240% vs. TMO: 53%
Market capitalization -- A: $35.5B vs. TMO: $184.93B
A [@Medical Specialties] is valued at $35.5B. TMO’s [@Medical Specialties] market capitalization is $184.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while TMO’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 3 bearish.
  • TMO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, A is a better buy in the short-term than TMO.

Price Growth

A (@Medical Specialties) experienced а +6.67% price change this week, while TMO (@Medical Specialties) price change was +1.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.84%. For the same industry, the average monthly price growth was +7.35%, and the average quarterly price growth was +7.20%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (-0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($185B) has a higher market cap than A($35.5B). A (29.20) and TMO (28.33) have similar P/E ratio . TMO YTD gains are higher at: -5.684 vs. A (-6.588). TMO has higher annual earnings (EBITDA): 11.3B vs. A (1.76B). TMO has more cash in the bank: 6.39B vs. A (1.49B). A has less debt than TMO: A (3.5B) vs TMO (35.2B). TMO has higher revenues than A: TMO (43.2B) vs A (6.63B).
ATMOA / TMO
Capitalization35.5B185B19%
EBITDA1.76B11.3B16%
Gain YTD-6.588-5.684116%
P/E Ratio29.2028.33103%
Revenue6.63B43.2B15%
Total Cash1.49B6.39B23%
Total Debt3.5B35.2B10%
FUNDAMENTALS RATINGS
A vs TMO: Fundamental Ratings
A
TMO
OUTLOOK RATING
1..100
7262
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
7177
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (46) in the Biotechnology industry is in the same range as TMO (71) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as TMO (77) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's SMR Rating (100) in the Biotechnology industry is in the same range as TMO (100) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

TMO's Price Growth Rating (55) in the Medical Specialties industry is in the same range as A (60) in the Biotechnology industry. This means that TMO’s stock grew similarly to A’s over the last 12 months.

TMO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as A (100) in the Biotechnology industry. This means that TMO’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATMO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 15 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 3 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GBAT1.950.15
+8.33%
Grayscale Basic Attention Token Trust (BAT)
MDIV16.250.07
+0.43%
Multi-Asset Diversified Income ETF
QRMI15.780.05
+0.32%
Global X NASDAQ 100® Risk Mngd Inc ETF
MSSS30.520.05
+0.16%
Monarch Select Subsector ETF
BSCP20.68N/A
N/A
Invesco BulletShares 2025 Corp Bd ETF